Juvenile myoclonic epilepsy age range from the initial manifestations to the first diagnosis

Authors

Keywords:

Juvenile myoclonic epilepsy, Diagnosis, Delay, Electroencephalography

Abstract

Juvenile myoclonic epilepsy is an genetic generalized epilepsy that presents with irregular myoclonic seizures, usually after awakening, and characteristic electroencephalographic findings. Of the examined 45 patients from the Department for Paroxysmal Conitions of the Multiprofile Hospital for Active Treatment in Neurology and Psychiatry „St. Naum”, Sofia, a delay was found in establishing the correct diagnosis and starting the corresponding treatment. The delay in the process of correct diagnosis ranges from 1 year to 56 years, and the age period of the initial manifestations of our patients is from 7 years to 28 years. There are significant gaps in the diagnosis and treatment of juvenile myoclonic epilepsy, which is due to incomplete anamnesis, insufficient electroencephalographic examination and untimely referral to specialized units and specialists.

References

Stefanova, I., Kuzmanova, R. Juvenile myoclonic epilepsy – etiology, pathogenesis, clinical symptoms and treatment. Cephalgia, 2012, 14, 2, 28-33. Available from https://glavobolie.org/journal/index.php/ce/issue/view/27/26

Atakli, D., Sozuer, D., Atay, T., et al. Misdiagnosis and treatment in juvenile myoclonic epilepsy.Seizure. 1998, 7, 63-6.

Czapinski, P.P., Czapinska, E.M. The effectiveness of levetiracetam in drug-resistant juvenile myoclonic epilepsy. Epilepsia. 2004;45, 3, 141.

Delgado-Escueta, A., Enrile-Bascal, F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984, 34, 285-94.

Delgado-Escueta, A.V., Serratosa. J.M., Medina, M.T. Juvenile myoclonic epilepsy. In: Wylie E, ed. The treatment of epilepsy: principles and practice. 2nd Ed. Baltimore: Williams & Wilkins, 1996, 484-51.

Disabato, J.A., Barnhurst, R.F., Levisohn, P.M., Efficacy of vagus nerve stimulation in young children with generalized epilepsies (abstract). Epilepsia, 2001, 42, 171.

Gelisse, P., Genton, P., Thomas, P., et al. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry, 2001, 70, 240-3.

Gruenwald, R., Chroni, E., Panayiotopoulos, C.P. Delayed diagnosis of juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry, 1992, 55, 497-9.

Janz, D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy) Acta Neurol Scand, 1985, 72, 449-459.

Lancman, M.E., Asconape, J.J., Penry, J.K. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia, 1994, 35, 302-6.

Resor, S.R., Resor, L.D. Levetiracetam monotherapy in the treatment of convulsive seizures in juvenile myoclonic epilepsy. Presented at the 54th Annual Meeting of the American Academy of Neurology; April 13–20 2002; Denver, CO. 2005.

Swartz, B.E., Simpkins, F., Halgren, E., et.al. Visual working memory in primary generalised epilepsy: an 18FDG-PET study. Neurology, 1996, 47, 1203-12.

Thomas, P., Valton, L., Genton, P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain, 2006, 129, 1281-92.

Published

30.12.2024

How to Cite

Vaneva, I. (2024). Juvenile myoclonic epilepsy age range from the initial manifestations to the first diagnosis. Movement Disorders Bulgaria, 21(1), 39–44. Retrieved from https://www.multiplesclerosis-bg.com/journal/index.php/md/article/view/80